How Ethos Sold Wall Street on AI While Powering an Analog Boiler Room
Jenny Ahn, Michelle Cera, Ruth Reader, Hunterbrook
Vytorin Cholesterol Pill
Merck has agreed to settle two class-action lawsuits filed in 2008 against it and Schering-Plough Corp. (which Merck has since acquired) over its cholesterol medication Vytorin. The settlement is for a whopping $688 million. The two lawsuits were filed by shareholders of the companies and alleged, among other things, that the companies made false and misleading statements regarding the effectiveness and economic success of the drug in press releases and other public disclosures.
The Latest
CATrends: Unscented Deodorants and Antiperspirants
Lawsuits allege marketing doesn’t pass the smell test.
HydroJug’s Heat-Retention Claims
Can these bottles really keep drinks hot for up to six hours?
With Personalized Pricing, Disclosure Is a Start, But Not a Finish Line
TINA.org and other consumer advocates file comment with FTC.
MLMs Are Consistently Leaving Participants Behind
New book explores why MLMs are often associated with harmful outcomes – and what can be done about it.